"Just Move It . . . Move It": A Multidisciplinary Motivational Approach to Improve Physical Activity in Children With

Valérie Sputael1, Véronique Gaspar1, Valentine Weber1

  • 1Queen Fabiola Children's University Hospital, Brussels, Belgium.

Insights

Motivational interviewing increased physical activity (PA) in pediatric cystic fibrosis (CF) patients. While PA duration rose, functional and nutritional improvements were not observed in this study.

Area of Science:

  • Pediatric Pulmonology
  • Behavioral Medicine
  • Exercise Science

Background:

  • Regular physical activity (PA) is crucial for managing cystic fibrosis (CF).
  • Pediatric CF patients often face challenges in maintaining consistent PA levels.
  • Motivational interviewing (MI) is a counseling approach that can facilitate behavior change.

Purpose of the Study:

  • To evaluate the effectiveness of an MI-based project ('Just move it... move it') in enhancing PA among pediatric CF patients.
  • To assess changes in PA duration, functional parameters, and nutritional status following the intervention.

Main Methods:

  • A 6-month project utilizing motivational interviewing (MI) during patient visits.
  • Nineteen pediatric CF patients were enrolled.
  • Data collected included body mass index, spirometry, extracurricular sport duration, and estimated maximal oxygen uptake (VO2max) at baseline and 6 months.

Main Results:

  • Over half of the participants (52.7%) increased their regular PA by an average of 1.9 hours/week (PA+ group).
  • The PA+ group showed a significant increase in extracurricular sport time compared to the PA- group.
  • No significant differences in body mass index, spirometric values, or VO2max were found between groups.

Conclusions:

  • The 'Just move it... move it' project successfully motivated a significant portion of pediatric CF patients to increase their PA.
  • While the intervention improved PA engagement, it did not lead to measurable improvements in functional or nutritional parameters within the study period.
  • MI appears to be an effective strategy for initiating or increasing PA in this population, warranting further investigation into its long-term effects.

Related Concept Videos

Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
208
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
2.6K
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
320
Chronic Obstructive Pulmonary Disease-V: Nursing Management01:30

Chronic Obstructive Pulmonary Disease-V: Nursing Management

Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
4.1K
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
265
Chronic Obstructive Pulmonary Disease01:22

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.3K